Corticosteroids prescription for mild-moderate COVID-19 in Primary Care

被引：2
|
作者：
Ordinola Navarro, Alberto [1 ]
Lopez Luis, Bruno Ali [2 ]
机构：
[1] Mexican Inst Social Secur, Antonio Fraga Mouret Specialty Hosp, La Raza Natl Med Ctr, Dept Internal Med, Mexico City, DF, Mexico
[2] Mexican Inst Social Secur, Gen Hosp 27, Dept Internal Med, Mexico City 06900, DF, Mexico
来源：
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES | 2021年 / 15卷 / 12期
关键词：
Corticosteroids; COVID-19; primary care;
D O I：
10.3855/jidc.15069
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：1813 / 1815
页数：3
相关论文
共 50 条
  • [1] Monoclonal Antibody Infusions for Outpatient Management of Mild-Moderate COVID-19
    Knox, Hannah B.
    Dykes, Lisa A.
    Scott, Lancer A.
    Presley, Bradley C.
    Lambert, Lara C.
    [J]. ANNALS OF PHARMACOTHERAPY, 2024, 58 (10) : 985 - 993
  • [2] Prediction of the Rehabilitation Duration and Risk Management for Mild-Moderate COVID-19
    Zheng, Qiong-Na
    Xu, Mei-Yan
    Zheng, Yong-Le
    Wang, Xiu-Ying
    Zhao, Hui
    [J]. DISASTER MEDICINE AND PUBLIC HEALTH PREPAREDNESS, 2020, 14 (05) : 652 - 657
  • [3] Cognitive impairment in people with COVID-19 with mild-moderate symptoms in Ecuador
    Checa, Alejandro
    Navas, Eliana
    Valencia, Veronica
    Alcivar, Jessica
    [J]. REVISTA MEXICANA DE NEUROCIENCIA, 2022, 23 (04): : 126 - 129
  • [4] Artificial intelligence for diagnosis of mild-moderate COVID-19 using haematological markers
    Chadaga, Krishnaraj
    Prabhu, Srikanth
    Bhat, Vivekananda
    Sampathila, Niranjana
    Umakanth, Shashikiran
    Chadaga, Rajagopala
    [J]. ANNALS OF MEDICINE, 2023, 55 (01)
  • [5] Oral antivirals for mild-moderate COVID-19: a panacea or a logistical and clinical conundrum?
    Coombes, Ian D.
    Legg, Amy
    Patterson, Tina
    Kelly, Tanya
    Henderson, Andrew
    Roberts, Jason A.
    [J]. AUSTRALIAN PRESCRIBER, 2022, 45 (02) : 67 - 68
  • [6] EARLY REMDESIVIR FOR VACCINATED KIDNEY TRANSPLANT RECIPIENTS WITH MILD-MODERATE COVID-19 INFECTION
    Hirsch, Daniel
    Sivanathan, Vithoo
    Agnew, Eleanor
    Kuhasri, Abidev
    Lee, Vivian
    Mcginn, Stella
    Li, Yan
    [J]. NEPHROLOGY, 2023, 28 : 57 - 58
  • [7] Decreased quality of life and spirometric alterations even after mild-moderate COVID-19
    Navarro, Alberto Ordinola
    Cervantes-Bojalil, Javier
    Cobos Quevedo, Orestes de Jesus
    Avila Martinez, Andrea
    Alberto Hernandez-Jimenez, Carlos
    Perez Alvarez, Esperanza
    Gonzalez Gil, Andrea
    Peralta Amaro, Ana Lilia
    Vera-Lastra, Olga
    Lopez Luis, Bruno Ali
    [J]. RESPIRATORY MEDICINE, 2021, 181
  • [8] Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19
    Adam K. Wheatley
    Jennifer A. Juno
    Jing J. Wang
    Kevin J. Selva
    Arnold Reynaldi
    Hyon-Xhi Tan
    Wen Shi Lee
    Kathleen M. Wragg
    Hannah G. Kelly
    Robyn Esterbauer
    Samantha K. Davis
    Helen E. Kent
    Francesca L. Mordant
    Timothy E. Schlub
    David L. Gordon
    David S. Khoury
    Kanta Subbarao
    Deborah Cromer
    Tom P. Gordon
    Amy W. Chung
    Miles P. Davenport
    Stephen J. Kent
    [J]. Nature Communications, 12
  • [9] Mild or Moderate Covid-19
    Gandhi, Rajesh T.
    Lynch, John B.
    del Rio, Carlos
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (18): : 1757 - 1766
  • [10] Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19
    Wheatley, Adam K.
    Juno, Jennifer A.
    Wang, Jing J.
    Selva, Kevin J.
    Reynaldi, Arnold
    Tan, Hyon-Xhi
    Lee, Wen Shi
    Wragg, Kathleen M.
    Kelly, Hannah G.
    Esterbauer, Robyn
    Davis, Samantha K.
    Kent, Helen E.
    Mordant, Francesca L.
    Schlub, Timothy E.
    Gordon, David L.
    Khoury, David S.
    Subbarao, Kanta
    Cromer, Deborah
    Gordon, Tom P.
    Chung, Amy W.
    Davenport, Miles P.
    Kent, Stephen J.
    [J]. NATURE COMMUNICATIONS, 2021, 12 (01)
12345